跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NDV-3
首页
药物
NDV-3
NDV-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
APMV AND USES THEREOF FOR THE TREATMENT OF CANCER
申请人: ICAHN SCHOOL MED MOUNT SINAI
优先权: 2018
CN
EP
US
WO
6 件公开
Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
申请人: UNIV MASSACHUSETTS
优先权: 2016
CN
US
4 件公开
Gallid alphaherpesvirus 3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry
申请人: FARM VETERINARIOS S A C
优先权: 2024
US
WO
2 件公开
Recombinant Newcastle disease virus RNA expression systems and vaccines
申请人: SINAI SCHOOL MEDICINE
优先权: 2002
US
Triple killed vaccine for fowl and method of preparing the same
申请人: LUOYANG PULAIKE BIOLOG ENGINEE
优先权: 2006
CN
Method for preparing tetrad inactivated vaccine of bird flu
申请人: LUOYANG PU LIKE BIO ENGINEERIN
优先权: 2008
CN
Method for preparing bigeminy inactivated vaccine of newcastledisease and H9 hypotype bird flu
申请人: LUOYANG PU LIKE BIO ENGINEERIN
优先权: 2008
CN
Method for preparing triple inactivated vaccine of chicken infectious bursal disease
申请人: LUOYANG PU LIKE BIO ENGINEERIN
优先权: 2008
CN
Construction of recombinant lactic acid bacteria with HN gene and F gene of Newcastle disease virus
申请人: UNIV JILIN AGRICULTURAL
优先权: 2008
CN
种融合细胞及其制备方法和其作为肿瘤疫苗的应用
申请人: 北京多赢时代科技有限公司
优先权: 2015
CN
第 1 / 3 页
上一页
下一页
药物
反馈